We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Companies Pool Interests to Develop Toponomics Platform

By Biotechdaily staff writers
Posted on 30 Jan 2003
A collaborative agreement to develop a new technology platform for managing the analysis of protein networks of whole cells in situ, known as topologic proteomics or toponomics, has been announced by MelTec GmbH (Magdeburg, Germany) and the Fraunhofer Institute for Applied Information Technology (FIT, Sankt Augustin, Germany). More...


Under the agreement, the two companies will work together to develop new software-based approaches to analyze and visualize protein networks and then correlate that data with results from in vitro and in vivo experiments. They will combine the robotic toponomics imaging technology of MelTec with the image management and proteomics software of FIT. The system will be designed to rapidly produce high-quality results for understanding how proteins impact a drug's effectiveness.

"Our alliance will allow us to create an integrated environment that enables biologists to quickly identify and validate functional aspects of living cells,” said Dr. Thomas Berlage, director of FIT.




Related Links:
MelTec
Fraunhofer Institute for Applied Information Technology

Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
New
HPV Molecular Test
BD Onclarity HPV Assay
New
Benchtop Thermomixer
Biometra TS1 ThermoShaker
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: An elevated neutrophil-to-lymphocyte ratio (NLR), a rato easily obtained from a routine blood count, was associated with both short- and long-term Alzheimer’s risk (photo credit: 123RF)

Routine Blood Count Ratio Linked to Future Alzheimer’s and Dementia Risk

Alzheimer’s disease and related dementias develop over years, making it difficult to identify at-risk patients before symptoms appear. Clinicians therefore need widely available laboratory markers that... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.